Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Bayer Ag Ord (BAYZF)

Bayer Ag Ord (BAYZF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
AI (artificial intelligence) - Businessman touching the brain working of Artificial Intelligence (AI) Automation by Suttiphong Chandaeng via Shutterstock
1 AI Biotech Stock That Just Scored a Major Milestone Barchart - Sat Oct 5, 7:15AM CDT

Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.

BAYZF : 20.4600 (-0.85%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
SNY : 47.98 (+0.42%)
Healthcare - iStock-1346675584
1 AI Growth Stock With 54% Upside Potential Barchart - Thu Mar 14, 7:30AM CDT

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered...

GS : 596.11 (+2.44%)
RXRX : 5.75 (-4.80%)
NVDA : 146.67 (+0.53%)
ARKK : 54.77 (-0.92%)
$SPX : 5,948.71 (+0.53%)
BAYZF : 20.4600 (-0.85%)
Why Regeneron Investors Shouldn't Fear Its Patent Cliff Motley Fool - Thu May 26, 2022

New treatments will step in to replace blockbuster eye medication EYLEA.

BAYZF : 20.4600 (-0.85%)
REGN : 744.50 (+0.15%)
AMGN : 289.90 (+0.71%)
NVS : 103.85 (+0.74%)
SNY : 47.98 (+0.42%)
Judicial Panel Rejects Bayer Monsanto Attempt to Thwart Fair Settlement for Roundup-Cancer Victims PR Newswire - Wed Oct 20, 2021

/PRNewswire/ -- A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits...

BAYZF : 20.4600 (-0.85%)

Barchart Exclusives

Up 99% in the Past Year, How High Can This Growth Stock Rise? Barchart - 43 minutes ago
With Lumentum shares skyrocketing over the past year, can this growth stock keep climbing? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot